These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 4717562)

  • 1. Prolonged survival of tumor allografts in mice pretreated with soluble transplantation antigens.
    Rosenberg EB; Hill J; Ferarri A; Herberman RB; Ting CC; Mann DL; Fahey J
    J Natl Cancer Inst; 1973 Jun; 50(6):1453-8. PubMed ID: 4717562
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific unresponsiveness to skin allografts in mice. I. Properties of tissue extracts and their synergistic effect with antilymphocytic serum.
    Brent L; Hansen JA; Kilshaw PJ; Thomas AV
    Transplantation; 1973 Jan; 15(1):160-71. PubMed ID: 4575919
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preferential efficicacy of immunocomplexes in the facilitation of tumor allografts].
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1973 Nov; 124(4):567-72. PubMed ID: 4134880
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar PB
    Transplant Proc; 1969 Mar; 1(1):429-32. PubMed ID: 4944254
    [No Abstract]   [Full Text] [Related]  

  • 6. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
    Cohen AM; Millar RC; Ketcham AS
    Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolongation of the survival of skin allografts by the injection of spleen cells in adult mice treated by antilymphocyte serum.
    Brochier J; Fries D
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):303-7. PubMed ID: 4559763
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological concepts relating to organ transplantation].
    Dei Poli G; Massa G; Rosso PA; Dei Poli N
    Minerva Chir; 1980 Jun; 35(11):829-78. PubMed ID: 6450338
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40.
    Drapkin MS; Appella E; Law LW
    J Natl Cancer Inst; 1974 Jan; 52(1):259-64. PubMed ID: 4129833
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerance, enhancement and prolonged survival of organ trnasplants.
    Halasz NA; Miller SH; Romolo JL
    Ann Surg; 1972 Oct; 176(4):538-43. PubMed ID: 4562065
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolongation of skin allograft survival with antilymphocyte serum and soluble histocompatibility antigens.
    Sumerska T; Betel I; Balner H; Warren HS
    Transplantation; 1974 Jan; 17(1):1-7. PubMed ID: 4148888
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of the immune response toward allografts in vivo. I. Selective suppression of the development of cell-mediated immunity by soluble alloantigens.
    Bonavida B; Zighelboim J
    Cell Immunol; 1974 Jul; 13(1):52-65. PubMed ID: 4451974
    [No Abstract]   [Full Text] [Related]  

  • 14. Indirect evidence of two adverse components of the humoral response to skin allografts as revealed in ALS-suppressed mice.
    Nouza K; Hilgert I; Nĕmec M; Kristofová H
    Folia Biol (Praha); 1972; 18(4):264-9. PubMed ID: 4559929
    [No Abstract]   [Full Text] [Related]  

  • 15. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
    Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 17. Surface H-2 antigen concentration requirement of somatic hybrid cells for IgM-mediated cytotoxicity.
    Rubio N
    Nature; 1974 May; 249(456):461-3. PubMed ID: 4134883
    [No Abstract]   [Full Text] [Related]  

  • 18. Soluble transplantation antigens. Further studies of their tolerogenic properties.
    Law LW; Appella E; Strober S; Wright PW; Fischetti T
    Transplantation; 1974 Dec; 18(6):487-95. PubMed ID: 4612886
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of macrophages in tumour immunity. 3. Co-operation between macrophages and lymphoid factors in an in vitro allograft situation.
    Evans R; Grant CK
    Immunology; 1972 Nov; 23(5):677-87. PubMed ID: 4673868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.